They joined us!
Creation: 13 février 2025
Employees: 2
Address: Grenoble (38)
Activity: Medtech
Who ?
nawu diagnostics develops a groundbreaking diagnostic equipment for respiratory infections, directly from the breath or ambient air. Our tool brings together into a compact object the steps of capturing the aerosols containing the viruses and bacteria, preparing the sample, and precisely identifying the pathogen through multiplex molecular analysis. Our microfluidics-based consumable requires no human operator, unlocking its autonomous usage outside of medical analysis laboratories. Our products allow the sensitive identification in 30 minutes of the pathogens infecting a sick individual, but also of germs circulating in the environment before the onset of an outbreak (semi-collective diagnostics or environmental monitoring). Through early detection of emerging pathogens, nawu diagnostics aims to limit epidemics and guide therapeutic and preventive decision-making.
Protected by 8 patents, the technology was incubated at CEA. In a true One Health approach, a first deployment is planned in animal health, before the product is introduced into human heath from 2030.
Why ?
“By joining Lyonbiopole, we want to get connected to the dense and dynamic regional biotech/medtech ecosystem, become a member of a community that helps us better grasp the pre-existing and emerging stakes and challenges of our specific field of activity, and benefit from guidance adapted to our activity and company maturity.”
Fanny TURLURE – CEO